039860 — NanoenTek Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapFalling Star

Annual income statement for NanoenTek, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	35,784	35,201	26,837	30,464	38,130
Cost of Revenue
Gross Profit	17,690	16,911	12,342	17,037	22,387
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	31,746	30,820	29,066	29,843	37,531
Operating Profit	4,038	4,381	-2,229	621	600
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	5,470	5,508	-1,205	3,718	1,059
Provision for Income Taxes
Net Income After Taxes	7,321	4,665	-3,678	3,586	1,580
Net Income Before Extraordinary Items
Net Income	7,321	4,665	-3,678	3,586	1,580
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	7,321	4,665	-3,678	3,586	1,580
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	303	174	-137	119	56.8
Dividends per Share